Wonderful news that will help our clinicians offer ActiGraft to treat more patients with chronic, hard-to-heal wounds in the convenience of their homes or at skilled nursing facilities. 🔗https://lnkd.in/gBd44VDm #HealingisinourBlood #ActiGraft #WholeBloodClot #ChronicWoundCare #WoundManagement #Bloodderived
RedDress Ltd.
Výroba zdravotnických prostředků
Ponte Vedra Beach, FL 3 041 sledující uživatelů
Healing is in Our Blood
O nás
RedDress, a private medical device company, developed a ground-breaking, advanced wound care solution based on a patented technology using a patient's own blood to harness body's natural process to heal wounds. The company based in Israel, was founded in 2009 by Dr. Igal Kushnir, MD and Alon Kushnir and is focused on developing effective solutions that improve patient outcomes. RedDress management has vast experience in bringing breakthrough medical ideas to successful commercialization.
- Web
-
http://reddressmedical.com
Externí odkaz pro organizaci RedDress Ltd.
- Obor
- Výroba zdravotnických prostředků
- Velikost společnosti
- 11 - 50 zaměstnanců
- Ústředí
- Ponte Vedra Beach, FL
- Typ
- Soukromá společnost
- Datum založení
- 2009
- Speciality
- wound care, wound healing, tissue repair, chronic ulcers, diabetic foot ulcers, pressure ulcer , venous ulcers, burns a wound dressing
Lokality
-
Primární
822 A1A North
Ste 310
Ponte Vedra Beach, FL 32082, US
-
Pardes Hanna-Karkur, 37011, IL
Zaměstnanci společnosti RedDress Ltd.
Aktualizace
-
Exploring continued advanced therapy options for patients facing complex wounds or navigating intricate reimbursement structures? Join us at the 14th annual American College of Wound Healing and Tissue Repair (ACWHTR) meeting. This year's theme, "Longitudinal Healing," reflects our shared goal of expanding the horizons of wound care through diverse modalities. ⭕ActiGraft, our innovative autologous point-of-care wound management solution created from a patient's whole blood, offers clinicians an ongoing, effective option to treat chronic wounds. We look forward to connecting with you! #ActiGraft #HealingisinourBlood #Woundmanagement #ChronicWounds #AdvancedWoundCare #ACWHTR2024
-
As we begin December, we continue to reflect upon nearly a year filled with gratitude and appreciation for the opportunities clinicians have provided us to enhance the quality of life for our patients. We thank Frank Aviles, PT,CWS,FACCWS,CLT-LANA,ALM,AWCC, and Elizabeth Faust for showcasing ActiGraft on Episode 25 of their educational YouTube channel, 📹“The Frank & Lizzie Show”. This episode, ‘Unlocking the potential of ActiGraft” provides essential insights for healthcare professionals looking to optimize wound management strategies. Frank & Lizzie engage with Rob Snyder, DPM, MSc, MBA, CWSP, FFPM RCPS(Glasg), Professor and Director of Clinical Research at Barry University, virtually and Kathleen D. Schaum, MS, reimbursement specialist, LIVE from the SAWC Fall studio in Las Vegas. Dr. Snyder discussed the growing body of evidence, including new, groundbreaking RCT supporting the use of ActiGraft for chronic wounds, and explored its integration into everyday practice. He highlighted its ease of use and MOA to enhance patient care. Kathleen shed light on the reimbursement landscape for this innovative autologous graft. Don't miss Dr. Snyder's expertise and the invaluable information he shares about this promising treatment modality. For more information on ActiGraft, visit https://lnkd.in/grdAwY7F. #education #ActiGraft #frankandlizzieshow #innovation #healingisinourblood #QoL #Chronicwounds #Woundcaremanagement https://lnkd.in/g4ystvaS
The Frank & Lizzie Show: Episode 025: Unlocking the Potential of the RedDress ActiGraft
https://www.youtube.com/
-
Big news today! LCDs for Cellular and Tissue-Based Products (CTP/Skin Substitutes grafts) for treating DFUs and VLUs were released today. As expected, CMS has proposed changes that will significantly limit these treatment options. Effective Feb 12, 2025, Skin Substitute grafts are limited to 4 applications but with documentation of medical necessity, up to 8 may be allowed. Must show a 50% reduction in wound size for additional applications past 4. Up to 16 weeks of treatment are allotted with documentation that includes progression of wound closure. Based on the RWE, · Only 17 grafts are now covered for DFUs · Only 5 grafts are now covered for VLUs Remember to attend the webinar by In-House CME today, which touches upon some of these changes. “Alternatives to Skin Substitutes” 🔗 Register here: https://lnkd.in/g7ZtXRyu This program will be a roundtable discussion, with 3 wound experts and a world-renowned expert in reimbursement and health insurance strategies. They will review innovative wound management treatment options unaffected by these changes and CMS changes announced, with commentary by a compliance expert, and how the proposed changes will affect wound care. Panelists: Kathleen D. Schaum, Dr. Windy Cole, DPM, CWSP, FFPM RCPS(Glasg), Dr. Raymond Abdo, Stephen Heisler DPM, MHSA #Autologousblood #Bloodderivedproducts #CMS #healingisinourblood #webinar #CME #podiatrists #innovation #paneldiscussion #LCDchanges #CME #patientoutcomes #evidencebasedpractice
-
We are excited to announce that the ActiGraft® Pro system is now available through Healogics Wound Care Supply’s (HWCS) group purchasing organization, iSupply. HWCS supports wound care treatment facilities by offering cost-saving product solutions for hospitals and patients through iSupply. It is designed to provide high-quality products with substantial facility-level cost savings. 🔗 Learn more: https://lnkd.in/g7ASD9nJ The Healogics team has almost 3,000 employees, 4,000 affiliated physicians, and a Healogics Specialty Physician practice group of nearly 300. In addition to the company’s network of outpatient centers, Healogics partners with 300+ skilled nursing facilities for patients with chronic wounds and provides inpatient consults at 60+ partner hospitals. #HealingisinourBlood #ActiGraft #woundcare #woundhealing #chronicwounds #woundcareteam #woundcarecenter #advancedwoundcare #woundmanagement
-
RedDress is honored to support this important and relevant CME webinar hosted by In-House CME in light of the upcoming CMS changes. Skin substitutes have become overwhelmingly popular as a wound-healing modality. Due to their high costs and possible overuse, CMS has proposed changes that could significantly curtail their use. This webinar aims to highlight wound management technologies unaffected by the proposed CMS skin substitute changes that clinicians should consider as part of their wound healing protocols. This will be a roundtable discussion, with 3 wound experts and a world-renowned expert in reimbursement and health insurance strategies. They will review innovative wound healing technologies, proposed CMS changes to skin substitutes, commentary by a compliance expert, and how the proposed changes will affect wound care. Panelists: Kathleen D. Schaum, Dr. Windy Cole, DPM, CWSP, FFPM RCPS(Glasg), Dr.Raymond Abdo, Stephen Heisler DPM, MHSA Register here: https://lnkd.in/g7ZtXRyu #Innovationinwoundcare #Autologouswoundmanagement #Bloodderivedproducts #ActiGraftPro #webinar #CME #podiatrists
-
Breaking News: ActiGraft Now on the National Fee Schedule for Private Practices! We’re excited to share that starting January 2025, CMS has set a national payment rate for ActiGraft (G0465) in physician offices with a reimbursement rate of $890! This new rate will be obligatory for all MACs, making it possible for private practices, not just HOPDs, to provide patients with top-tier wound care. This key milestone brings ActiGraft’s innovative wound care solutions within reach of more clinics nationwide, simplifying access to advanced healing options and driving better patient outcomes. Thank you to everyone who contributed to this achievement—together, we’re transforming the future of wound healing! #ActiGraft #WoundCare #HealthcareInnovation #PatientCare #WoundHealing #PrivatePractice #HealingisinOurBlood Let’s connect to explore the next steps with ActiGraft.
-
We are excited to share that ActiGraft Pro has been added to the Wound Care Advantage (WCA) Formulary after a comprehensive evaluation by the WCA Product Council, a team of wound care experts. The WCA Product Council reviews products for safety, effectiveness, and accessibility for wound centers. https://lnkd.in/g8REx5qM WCA’s mission is to eliminate unnecessary amputations in our lifetime and believes every community should have access to a comprehensive, financially sustainable wound care program. With 20+ years of experience, WCA supports a national network of wound centers with a strong focus on reducing costs and improving patient outcomes. The centers have access to the formulary for comprehensive education and information, allowing providers to make well-informed decisions that best support their patients’ care. Since receiving FDA clearance and a CE Mark in 2020, ActiGraft has helped over 7,000 patients across the spectrum of healthcare facilities in the USA and 30 other countries. Let’s connect to explore the next steps with ActiGraft at your facility. #HealingisinourBlood #ActiGraft #WoundCare #WoundCareInnovation #Woundle #WoundHealing #WoundCenter #WoundCareCenter #WoundProgram #Outpatient #OutpatientWoundCare #WCA #TheWCA
-
It's a wrap! Thank you to all who dropped by our booth at SAWC Fall in Las Vegas and discussed the recently published ActiGraft's multinational RCT-backed landmark healing results in treating chronic wounds. We look forward to connecting with you at your clinics and supporting you and your patients as we embark on the ActiGraft healing journey together. Learn more: https://lnkd.in/gYS6NAD5 #HealingisinourBlood #chronicwounds #woundmangement #ActiGraftPro #clinicalevidence #patientoutcomes
-
SAWC Fall Day 1: What a great start for us! A very special thanks to the Frank N Lizzie Show discussing the blood-derived products category, and ActiGraft at the SAWC Live Studio today! In this episode,Dr. Rob Snyder, DPM, MSc, MBA, CWSP, FFPM RCPS(Glasg) and Kathleen D. Schaum discuss ActiGraft's latest RCT's published results - clinically proven fast and efficacious healing of chronic DFU's, and the significance of its National Coverage Determination status (NCD 270.3). Stay tuned as the episode will be live soon on their channel. Elizabeth Faust Frank Aviles, PT,CWS,FACCWS,CLT-LANA,ALM,AWCC Visit us at Booth 210 to learn more about the power of ActiGraft Whole Blood Clot. https://lnkd.in/gYS6NAD5 #SAWCFall2024 #ChronicWoundCare #FrankNLizzieShow